TOPIGEN PHARMA INC has a total of 23 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NEURONYX INC, THERAPTOSIS and VET STEM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | New Zealand | 3 | |
#5 | China | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Sugars | |
#5 | Analysing materials | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Renzi Paolo | 18 |
#2 | Zemzoumi Khalid | 11 |
#3 | Allakhverdi Zoulfia | 5 |
#4 | Allam Mustapha | 4 |
#5 | D Anjou Helene | 4 |
#6 | Helene Paolo Renzi Zemzoumi Kh | 1 |
#7 | Paolo Renzie | 1 |
#8 | Anjou Helene D | 1 |
#9 | Paolo Renzi | 1 |
#10 | Khalid Zemzoumi | 1 |
Publication | Filing date | Title |
---|---|---|
EP1668024A2 | Oligonucleotide compositions and methods for treating disease including inflammatory conditions | |
CA2456928A1 | Cellular virus receptors and methods of use | |
US7745420B2 | Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals | |
EP1088065A2 | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |